Annual Cash & Cash Equivalents
$6.54 B
+$4.86 B+289.77%
March 31, 2024
Summary
- As of February 7, 2025, ROIV annual cash & cash equivalents is $6.54 billion, with the most recent change of +$4.86 billion (+289.77%) on March 31, 2024.
- During the last 3 years, ROIV annual cash & cash equivalents has risen by +$4.48 billion (+218.03%).
- ROIV annual cash & cash equivalents is now at all-time high.
Performance
ROIV Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.96 B
-$3.72 B-65.51%
September 30, 2024
Summary
- As of February 7, 2025, ROIV quarterly cash and cash equivalents is $1.96 billion, with the most recent change of -$3.72 billion (-65.51%) on September 30, 2024.
- Over the past year, ROIV quarterly cash and cash equivalents has dropped by -$4.58 billion (-70.03%).
- ROIV quarterly cash and cash equivalents is now -70.64% below its all-time high of $6.67 billion, reached on December 31, 2023.
Performance
ROIV Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ROIV Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +289.8% | -70.0% |
| 3 y3 years | +218.0% | -4.9% |
| 5 y5 years | +218.0% | -4.9% |
ROIV Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +289.8% | -70.6% | +39.1% |
| 5 y | 5-year | at high | +289.8% | -70.6% | +39.1% |
| alltime | all time | at high | +289.8% | -70.6% | +39.1% |
Roivant Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.96 B(-65.5%) |
| Jun 2024 | - | $5.68 B(-13.1%) |
| Mar 2024 | $6.54 B(+289.8%) | $6.54 B(-2.0%) |
| Dec 2023 | - | $6.67 B(+373.7%) |
| Sep 2023 | - | $1.41 B(-1.8%) |
| Jun 2023 | - | $1.43 B(-14.5%) |
| Mar 2023 | $1.68 B | $1.68 B(+9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | - | $1.53 B(-4.5%) |
| Sep 2022 | - | $1.60 B(-17.7%) |
| Jun 2022 | - | $1.94 B(-5.7%) |
| Mar 2022 | $2.06 B(+0.3%) | $2.06 B(-6.9%) |
| Dec 2021 | - | $2.21 B(-11.3%) |
| Sep 2021 | - | $2.50 B(+25.1%) |
| Jun 2021 | - | $2.00 B(-2.8%) |
| Mar 2021 | $2.06 B | $2.06 B |
FAQ
- What is Roivant Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Roivant Sciences?
- What is Roivant Sciences annual cash & cash equivalents year-on-year change?
- What is Roivant Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Roivant Sciences?
- What is Roivant Sciences quarterly cash and cash equivalents year-on-year change?
What is Roivant Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ROIV is $6.54 B
What is the all time high annual cash & cash equivalents for Roivant Sciences?
Roivant Sciences all-time high annual cash & cash equivalents is $6.54 B
What is Roivant Sciences annual cash & cash equivalents year-on-year change?
Over the past year, ROIV annual cash & cash equivalents has changed by +$4.86 B (+289.77%)
What is Roivant Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ROIV is $1.96 B
What is the all time high quarterly cash and cash equivalents for Roivant Sciences?
Roivant Sciences all-time high quarterly cash and cash equivalents is $6.67 B
What is Roivant Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ROIV quarterly cash and cash equivalents has changed by -$4.58 B (-70.03%)